Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.
The official print number for this legislation is 117_HCONRES_42.
This legislation was initiated in the House of Representatives.
The process officially started on 2021-07-21.
Key points include:
The current status is Expired.
The full official text is available at: View full text
The primary sponsor is Rep. McKinley, David B. [R-WV-1].
The latest detailed status is: Referred to the Subcommittee on Health.
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.